N6-methyladenosine (m6A)-mediated lncRNA DLGAP1-AS1enhances breast canceradriamycin resistance through miR-299-3p/WTAP feedback loop
Authors:
Open Access
- 4 December 2021
- journal article
- research article
- Published by Taylor & Francis in Bioengineered
- Vol. 12 (2) , 10935-10944
Abstract
Chemotherapy resistance is identified as an obstacle for breast cancer (BC) therapy, and, besides, increasing evidence indicates that long-noncoding RNAs (lncRNAs) participate in the regulation of BC adriamycin (ADR) resistance. Here, our work shows that lncRNA DLGAP1 antisense RNA 1 (DLGAP1-AS1) is up-regulated in ADR-resistant BC cells (MCF-7/ADR). Clinically, higher DLGAP1-AS1 expression was closely correlated to poorer clinical prognosis. Results showed that DLGAP1-AS1 promoted the ADR IC50 and proliferation of ADR-resistant cells. Moreover, N6-methyladenosine (m6A) methyltransferase WT1 associated protein (WTAP) binds to the m6A modified site of DLGAP1-AS1 and motivates its stability. Mechanistically, DLGAP1-AS1 sponged miR-299-3p through 3ʹ-untranslated region (3ʹ-UTR) binding, which in turn relieved the repression of WTAP and thus upregulated WTAP expression. In conclusion, above findings conclude that lncRNA DLGAP1-AS1 promotes BC ADR-resistance through WTAP/DLGAP1-AS1/miR-299-3p feedback loop.Keywords
Funding Information
- No funding
This publication has 29 references indexed in Scilit:
- Metformin in breast cancer: preclinical and clinical evidenceCurrent Problems in Cancer, 2020
- IGF2BP2 regulates DANCR by serving as an N6-methyladenosine readerCell Death & Differentiation, 2019
- Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3Molecular Cancer, 2019
- Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistanceOncogene, 2019
- Long Non-Coding RNA in the Pathogenesis of CancersCells, 2019
- Long Non-coding RNA in CNS Injuries: A New Target for Therapeutic InterventionMolecular Therapy Nucleic Acids, 2019
- Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the ChallengeCells, 2019
- The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of CYR61 mRNATheranostics, 2019
- SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancerJournal of Experimental & Clinical Cancer Research, 2018
- High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer ChemotherapyChemotherapy, 2017